Skip to main content
SpringerLink
Log in

Targeting cIAPs, a New Option for Functional Cure of Chronic Hepatitis B Infection?

  • PERSPECTIVE
  • Published:
Virologica Sinica

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  • Beug ST, Cheung HH, LaCasse EC, Korneluk RG (2012) Modulation of immune signalling by inhibitors of apoptosis. Trends Immunol 33:535–545

    Article  CAS  Google Scholar 

  • Block TM, Alter H, Brown N, Brownstein A, Brosgart C, Chang KM, Chen PJ, Cohen C, El-Serag H, Feld J, Gish R, Glenn J, Greten TF, Guo JT, Hoshida Y, Kowdley KV, Li W, Lok AS, McMahon B, Mehta A, Perrillo R, Rice CM, Rinaudo J, Schinazi RF, Shetty K (2018) Research priorities for the discovery of a cure for chronic hepatitis B: report of a workshop. Antivir Res 150:93–100

    Article  CAS  Google Scholar 

  • Chesi M, Mirza NN, Garbitt VM, Sharik ME, Dueck AC, Asmann YW, Akhmetzyanova I, Kosiorek HE, Calcinotto A, Riggs DL, Keane N, Ahmann GJ, Morrison KM, Fonseca R, Lacy MQ, Dingli D, Kumar SK, Ailawadhi S, Dispenzieri A, Buadi F, Gertz MA, Reeder CB, Lin Y, Chanan-Khan AA, Stewart AK, Fooksman D, Bergsagel PL (2016) IAP antagonists induce anti-tumor immunity in multiple myeloma. Nat Med 22:1411–1420

    Article  CAS  Google Scholar 

  • Ebert G, Allison C, Preston S, Cooney J, Toe JG, Stutz MD, Ojaimi S, Baschuk N, Nachbur U, Torresi J, Silke J, Begley CG, Pellegrini M (2015a) Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis. Proc Natl Acad Sci USA 112:5803–5808

    Article  CAS  Google Scholar 

  • Ebert G, Preston S, Allison C, Cooney J, Toe JG, Stutz MD, Ojaimi S, Scott HW, Baschuk N, Nachbur U, Torresi J, Chin R, Colledge D, Li X, Warner N, Revill P, Bowden S, Silke J, Begley CG, Pellegrini M (2015b) Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proc Natl Acad Sci USA 112:5797–5802

    Article  CAS  Google Scholar 

  • Estornes Y, Bertrand MJ (2015) IAPs, regulators of innate immunity and inflammation. Semin Cell Dev Biol 39:106–114

    Article  CAS  Google Scholar 

  • European Association for the Study of the Liver (2017) EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 67:370–398

    Article  Google Scholar 

  • Guidotti LG, Inverso D, Sironi L, Di Lucia P, Fioravanti J, Ganzer L, Fiocchi A, Vacca M, Aiolfi R, Sammicheli S, Mainetti M, Cataudella T, Raimondi A, Gonzalez-Aseguinolaza G, Protzer U, Ruggeri ZM, Chisari FV, Isogawa M, Sitia G, Iannacone M (2015) Immunosurveillance of the liver by intravascular effector CD8(+) T cells. Cell 161:486–500

    Article  CAS  Google Scholar 

  • Li N, Feng L, Han HQ, Yuan J, Qi XK, Lian YF, Kuang BH, Zhang YC, Deng CC, Zhang HJ, Yao YY, Xu M, He GP, Zhao BC, Gao L, Feng QS, Chen LZ, Yang L, Yang D, Zeng YX (2016) A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis. Cancer Lett 381:14–22

    Article  CAS  Google Scholar 

  • Li BX, Wang HB, Qiu MZ, Luo QY, Yi HJ, Yan XL, Pan WT, Yuan LP, Zhang YX, Xu JH, Zhang L, Yang DJ (2018) Novel smac mimetic APG-1387 elicits ovarian cancer cell killing through TNF-alpha, Ripoptosome and autophagy mediated cell death pathway. J Exp Clin Cancer Res 37:53

    Article  Google Scholar 

  • Lok AS, Zoulim F, Dusheiko G, Ghany MG (2017) Hepatitis B cure: from discovery to regulatory approval. Hepatology 66:1296–1313

    Article  Google Scholar 

  • Ott JJ, Stevens GA, Groeger J, Wiersma ST (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30:2212–2219

    Article  CAS  Google Scholar 

  • Pan W, Luo Q, Yan X, Yuan L, Yi H, Zhang L, Li B, Zhang Y, Sun J, Qiu MZ, Yang DJ (2018) A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity. Biochem Pharmacol 154:127–135

    Article  CAS  Google Scholar 

  • Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, Kim JH, Lai CL, Lee HC, Lim SG, Liu CJ, Locarnini S, Al Mahtab M, Mohamed R, Omata M, Park J, Piratvisuth T, Sharma BC, Sollano J, Wang FS, Wei L, Yuen MF, Zheng SS, Kao JH (2016) Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 10:1–98

    Article  CAS  Google Scholar 

  • Tang LSY, Covert E, Wilson E, Kottilil S (2018) Chronic hepatitis B infection: a review. JAMA 319:1802–1813

    Article  CAS  Google Scholar 

  • Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB (2018) Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67:1560–1599

    Article  Google Scholar 

  • Wang Z, Ni J, Li J, Shi B, Xu Y, Yuan Z (2011) Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin–proteasome-mediated destruction of polymerase. J Virol 85:11457–11467

    Article  CAS  Google Scholar 

  • Xu R, Li Y, Ji J, Qiu M, Zhang Y, Liu W, Tian X, Li S, Wang H, Wang F, Zhang D, Wang F, Wang Z, Luo H, Zou B, Wang D, Ren C, Jin Y, Zhai Y, Yang D (2018) A phase I study of a novel IAP inhibitor APG-1387 in patients with advanced solid tumors. J Clin Oncol 36:15_suppl, 2593

    Article  Google Scholar 

  • Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL (2018) Hepatitis B virus infection. Nat Rev Dis Primers 4:18035

    Article  Google Scholar 

Download references

Acknowledgements

This work was partly supported by Grants from the National Natural Science Foundation of China (81641173) and the Collaboration and Innovation Health Care Major Project of Guangzhou (201604020010).

Author information

Authors and Affiliations

  1. State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China

    Hongyan Liu, Jinlin Hou & Xiaoyong Zhang

Authors
  1. Hongyan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jinlin Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaoyong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaoyong Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Animal and Human Rights Statement

The authors declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, H., Hou, J. & Zhang, X. Targeting cIAPs, a New Option for Functional Cure of Chronic Hepatitis B Infection?. Virol. Sin. 33, 459–461 (2018). https://doi.org/10.1007/s12250-018-0062-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-018-0062-x

Keywords

Search

Navigation